ATTD: Advanced Technologies and Treatments for Diabetes

ATTD on UNLOK
  • 0.0 (0)
  • LIFE SCIENCES

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom). Whether you're a specialist, researcher, or industry leader, hit subscribe.

  1. Principles of Basal Insulin Therapy in Type 2 Diabetes

    3D AGO

    Principles of Basal Insulin Therapy in Type 2 Diabetes

    In our new series, Insulin in Practice, host Dr Bob Gabbay looks at the principles of Basal Insulin Therapy in Type 2 Diabetes; its physiological role, pharmacodynamics, and current guideline-based use. He is joined by Dr Giulio Romeo. They discuss: The role of basal insulin in normal physiology and why it matters in Type 2 diabetes Goals of basal insulin therapy What makes new basal insulins different Current guidelines and recommendations for basal insulin therapy Alternatives to basal insulin therapy Tips for safe and effective initiation and titration Dr Giulio Romeo is Associate Medical Director of the Adult Diabetes Section at Joslin Diabetes Center, and Assistant Professor of Medicine, Harvard Medical School. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    18 min
  2. Advancements in Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    MAR 14

    Advancements in Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Advancements in Type 1 Diabetes: From Pathogenesis to Therapy, featuring the latest breakthroughs in understanding and treating Type 1 diabetes, from viral triggers to novel treatment strategies.  Join us as we summarize key takeaways from these thought-provoking presentations:  Role of Viruses in Pathogenesis of Type 1 Diabetes – Dr. Teresa Rodriguez-Calvo  Dendritic Cells for Treatment of Type 1 Diabetes – Dr. Jason Gaglia  C-Peptide: A Marker for Functional Beta Cell Mass? – Prof. Chantal Mathieu  This episode is an essential listen for endocrinologists, researchers, and healthcare professionals specializing in diabetes care, providing insights into the evolving landscape of Type 1 diabetes pathogenesis and the potential of dendritic cell therapies.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

    22 min
  3. ATTD AI School for Clinicians, ATTD 2026 Conference Catch-Up

    MAR 14

    ATTD AI School for Clinicians, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into ATTD AI School for Clinicians: From GenAI Foundations to Agentic CDSS Workflows - Safe, Practical Use in Diabetes Care, where we explore the application of AI technologies in diabetes care, focusing on safety, ethics, and practical use.  Join us as we summarize key takeaways from these thought-provoking presentations:  Welcome & Framing – Dr. Amit Dey & Prof. Peter Schwarz  Foundations of AI & Gen-AI for Clinicians – Dr. Amit Dey  Agentic AI & CDSS Workflows in Diabetes Care – Dr. Revital Nimri  Ethics, EU AI Act & GDPR Essentials for Clinicians – Lucía Feito Allonca  This episode is an essential listen for clinicians, diabetes specialists, and healthcare professionals seeking to understand the practical, safe, and ethical integration of GenAI and AI-driven clinical decision support systems (CDSS) in diabetes care.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

    19 min
  4. Continuous Glucose Monitoring Outside the Traditional Areas, ATTD 2026 Conference Catch-Up

    MAR 14

    Continuous Glucose Monitoring Outside the Traditional Areas, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) Outside the Traditional Areas, exploring innovative applications of CGM beyond its conventional use in diabetes management.  Join us as we summarize key takeaways from these thought-provoking presentations:  CGM As a Guide to Lifestyle and Weight Management – Dr. Nicola Guess  CGM in Non-diabetic Hypoglycaemia (Insulinoma, Post-bariatric / Reactive) – Dr. Robert Andrews  Non-invasive Glucose Monitoring – Dr. Lutz Heinemann  CGM Use in Clinical Trials – Prof. Pratik Choudhary  This episode is an essential listen for endocrinologists, clinical researchers, and healthcare professionals looking to explore the expanding role of CGM in lifestyle management, non-diabetic hypoglycaemia, and innovative clinical applications.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

    24 min
  5. Cardiovascular Disease in Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    MAR 14

    Cardiovascular Disease in Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Cardiovascular Disease in Type 1 Diabetes, featuring expert perspectives on cardiometabolic risk factors, prevention strategies, and evolving treatment approaches in people living with Type 1 diabetes.  While cardiovascular disease is often associated with Type 2 diabetes, growing evidence highlights the significant cardiovascular burden in individuals with Type 1 diabetes. This session explores the mechanisms, clinical risk factors, and multidisciplinary interventions that can help reduce long-term cardiovascular complications in this population.  Join us as we summarize key takeaways from these thought-provoking presentations:  • Coronary Heart Disease in T1D, Is It Different Than in T2D? – Dr. Robert H. Eckel  • Targets and Best Therapies for Blood Pressure and Cholesterol – Oliver Schnell  • Physical Activity for Cardiometabolic Risk Reduction in Type 1 Diabetes – Prof. Kirsten Nørgaard  • Understanding the Etiology and Best Treatment Strategies for Obesity in Type 1 Diabetes – Dr. Irl B. Hirsch  This episode is an essential listen for endocrinologists, diabetologists, cardiometabolic specialists, and healthcare professionals involved in diabetes care looking to better understand cardiovascular risk management and prevention strategies in people with Type 1 diabetes.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona.  https://attd.kenes.com

    24 min
  6. Refining Care of Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    MAR 14

    Refining Care of Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Refining Care of Type 1 Diabetes, featuring the latest advancements and strategies aimed at improving the care and outcomes for individuals living with Type 1 diabetes.  Join us as we summarize key takeaways from these thought-provoking presentations:  Refining Care of Type 1 Diabetes – Dr. Lori Laffel  Improving Glycemic Control and Reducing Diabetes Distress: A 2-way Street – Prof. Katharine Barnard-Kelly  Targeting Lower Glucose Levels in Children with Type 1 Diabetes – Dr. David M. Maahs  Inhaled Insulin Use in Pediatrics – Inhale 1 Study – Dr. Roy W. Beck  This episode is an essential listen for endocrinologists, pediatric specialists, and healthcare professionals involved in diabetes care, looking to refine their approach to treating Type 1 diabetes with the latest research findings and practical strategies.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

    17 min
  7. Managing Overweight & Obesity in T1D, ATTD 2026 Conference Catch-Up

    MAR 14

    Managing Overweight & Obesity in T1D, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Managing Overweight & Obesity in Type 1 Diabetes, featuring expert insights on multidisciplinary strategies to address weight management in people living with Type 1 diabetes.  As the prevalence of overweight and obesity increases among individuals with Type 1 diabetes, clinicians are facing new challenges that extend beyond glycemic control. This session explores the role of behavioral, nutritional, and therapeutic approaches in supporting sustainable weight management while maintaining optimal diabetes outcomes.  Join us as we summarize key takeaways from these thought-provoking presentations:  • The Role of Psychological Interventions in Promoting Sustainable Weight Loss – Alon Liberman  • Essential Nutrition Support for GLP-1/GIP Therapy Success – Dr. Adrian Brown  • Beyond Glycemia: Addressing Overweight and Obesity in Type 1 Diabetes – Prof. Lia Bally  This episode is an essential listen for endocrinologists, diabetologists, dietitians, and healthcare professionals involved in diabetes care looking to better understand multidisciplinary approaches to weight management in people with Type 1 diabetes.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona.  https://attd.kenes.com

    18 min
  8. Adjunct Therapies with Automated Insulin Delivery, ATTD 2026 Conference Catch-Up

    MAR 14

    Adjunct Therapies with Automated Insulin Delivery, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Adjunct Therapies with Automated Insulin Delivery, featuring new clinical evidence on combining automated insulin delivery (AID) systems with adjunct pharmacological therapies to improve outcomes in Type 1 diabetes.  As diabetes technology continues to evolve, researchers are exploring how therapies traditionally used in Type 2 diabetes-such as SGLT-2 inhibitors and GLP-1 receptor agonists-may complement automated insulin delivery systems to optimize glycemic control and potentially improve cardiometabolic outcomes.  Join us as we summarize key takeaways from these thought-provoking presentations:  • ADJUST T1D Study – Design and Glycemic Outcome – Dr. Viral N. Shah (United States of America) presents the study design and early glycemic outcomes of the ADJUST T1D trial, evaluating the impact of adjunct therapies alongside automated insulin delivery.  • ADJUST T1D Study – Cardiovascular Outcomes – Dr. Janet K. Snell-Bergeon  • Concurrent Use of AID with SGLT-2 – Dr. Ahmad Haidar • Real-Life Data on GLP Use in Type 1 Diabetes – Associate Professor Francisco J. Pasquel  This episode is an essential listen for endocrinologists, diabetologists, clinical researchers, and healthcare professionals involved in diabetes technology looking to understand emerging strategies that combine automated insulin delivery with adjunct pharmacological therapies to enhance diabetes management.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona.  https://attd.kenes.com

    22 min
See All (66)

Trailers

About

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom). Whether you're a specialist, researcher, or industry leader, hit subscribe.

Information

You Might Also Like